- Home
- RLAY vs BWBBP Comparison
RLAY vs BWBBP Comparison
Compare RLAY & BWBBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- BWBBP
- Stock Information
- Founded
- RLAY 2015
- BWBBP N/A
- Country
- RLAY United States
- BWBBP United States
- Employees
- RLAY N/A
- BWBBP 290
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- BWBBP Major Banks
- Sector
- RLAY Health Care
- BWBBP Finance
- Exchange
- RLAY Nasdaq
- BWBBP Nasdaq
- Market Cap
- RLAY 576.1M
- BWBBP N/A
- IPO Year
- RLAY 2020
- BWBBP N/A
- Fundamental
- Price
- RLAY $3.52
- BWBBP $19.00
- Analyst Decision
- RLAY Strong Buy
- BWBBP
- Analyst Count
- RLAY 11
- BWBBP 0
- Target Price
- RLAY $18.40
- BWBBP N/A
- AVG Volume (30 Days)
- RLAY 1.5M
- BWBBP N/A
- Earning Date
- RLAY 08-05-2025
- BWBBP N/A
- Dividend Yield
- RLAY N/A
- BWBBP N/A
- EPS Growth
- RLAY N/A
- BWBBP N/A
- EPS
- RLAY N/A
- BWBBP N/A
- Revenue
- RLAY $7,679,000.00
- BWBBP N/A
- Revenue This Year
- RLAY $17.59
- BWBBP N/A
- Revenue Next Year
- RLAY N/A
- BWBBP N/A
- P/E Ratio
- RLAY N/A
- BWBBP N/A
- Revenue Growth
- RLAY N/A
- BWBBP N/A
- 52 Week Low
- RLAY $1.78
- BWBBP N/A
- 52 Week High
- RLAY $10.72
- BWBBP N/A
- Technical
- Relative Strength Index (RSI)
- RLAY 54.94
- BWBBP 61.72
- Support Level
- RLAY $3.50
- BWBBP $18.51
- Resistance Level
- RLAY $3.74
- BWBBP $18.58
- Average True Range (ATR)
- RLAY 0.18
- BWBBP 0.09
- MACD
- RLAY -0.00
- BWBBP 0.07
- Stochastic Oscillator
- RLAY 58.55
- BWBBP 100.00
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About BWBBP Bridgewater Bancshares Inc. Depositary Shares Each Representing a 1/100th Interest in a Share of 5.875% Non-Cumulative Perpetual Preferred Stock Series A
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.